Mode
Text Size
Log in / Sign up

Review of observational data on pneumonia biomarkers in Kenyan children

Review of observational data on pneumonia biomarkers in Kenyan children
Photo by Navy Medicine / Unsplash
Key Takeaway
Note that current biomarkers and clinical signs failed to reliably distinguish bacterial from viral pneumonia in this Kenyan cohort.

This narrative review synthesizes data from a single observational study conducted at Kilifi County Referral Hospital, Kenya. The investigation focused on children aged 2-59 months admitted with pneumonia, aiming to differentiate bacterial from viral causes using clinical presentations and biomarkers. A total of 457 patients were included in the analysis. The primary outcome assessed was the ability to distinguish pneumonia etiology, while secondary outcomes were not reported in the source text. Safety data, including adverse events or tolerability, were not reported for this observational context.

The study employed multivariable Poisson regression models incorporating various biomarkers and clinical signs. In the crude analysis, chest-wall indrawing, cough, convulsions, crackles, angiotensinogen, and Serpin Family A Member 1 were significantly associated with pneumonia etiology. However, after controlling for age in the multivariable analysis, only chest-wall indrawing remained a significant association. The prevalence of severe pneumonia was 63% overall, with 72% observed in viral cases and 54% in bacterial cases. The model discrimination capability was quantified with an Area Under the Curve of 0.61.

The authors highlight a critical limitation: a wide range of biomarkers and clinical presentations failed to reliably distinguish bacterial from viral pneumonia. This finding suggests that current diagnostic markers may have limited utility in this specific setting. The follow-up duration was not reported, and the study phase was not specified. Given the observational nature of the data, causal language is avoided, and the results should be interpreted with caution regarding generalizability. Practice relevance was not explicitly reported by the authors, though the modest model performance suggests current diagnostic approaches may need refinement.

Study Details

Sample sizen = 229
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
BackgroundTo date, accessible diagnostic tools to identify whether a patients pneumonia is a bacterial, or viral infection, are not accurate or timely enough to prevent preemptive antibiotic administration. Relying on single biomarkers or clinical presentations has been insufficient. We aimed to incorporate a wide range of novel biomarkers and clinical presentations in a multivariable model and validate its capacity to differentiate cases of bacterial and viral pneumonia. MethodsData from 457 children aged 2-59 months, admitted to Kilifi County Referral Hospital, Kenya, with bacterial (n = 229) and viral (n = 228) infections, were used to develop and validate a predictive multivariable Poisson regression model to differentiate pneumonia etiology. The Receiver Operating Characteristic curve was used to assess biomarker performance and validate the model internally. ResultsSixty-three percent (63%) of the children presented with severe pneumonia. 72% with viral pneumonia had severe pneumonia, compared to 54% with bacterial pneumonia who had severe pneumonia. In crude analyses, chest-wall indrawing, cough, convulsions, crackles, angiotensinogen, and Serpin Family A Member 1 were significantly associated with pneumonia etiology, controlling for age. However, only chest-wall indrawing remained significant in multivariable analyses after controlling for age. The model demonstrated fair, but inadequate, discrimination, with an Area Under the Curve of 0.61. ConclusionAmong the children admitted to hospital with WHO defined pneumonia, a wide range of biomarkers and clinical presentations still failed to distinguish bacterial from viral pneumonia.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.